SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Diego Santos García, Juan Carlos Martínez Castrillo, Víctor Puente Périz, Agustín Seoane Urgorri, Servando Fernández Díez, Vicente Benita León, Beatriz Udaeta Baldivieso, Antonia Campolongo Perillo, Natividad Mariscal Pérez, Clinical management of patients with advanced Parkinson’s disease treated with continuous intestinal infusion of levodopa/carbidopa, Neurodegenerative Disease Management, 2016,

    CrossRef

  2. 2
    Peter J. Podgorny, Oksana Suchowersky, Kenneth G. Romanchuk, Thomas E. Feasby, Evidence for small fiber neuropathy in early Parkinson's disease, Parkinsonism & Related Disorders, 2016,

    CrossRef

  3. 3
    Florence C.F. Chang, Vu Kwan, David van der Poorten, Neil Mahant, Nigel Wolfe, Ainhi D. Ha, Jane M. Griffith, David Tsui, Samuel D. Kim, Victor S.C. Fung, Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson’s disease, Journal of Clinical Neuroscience, 2016, 25, 41

    CrossRef

  4. 4
    Thomas Müller, Horst Baas, Jan Kassubek, Peter Riederer, Peter Paul Urban, Christoph Schrader, Heinz Reichmann, Dirk Woitalla, Manfred Gerlach, Laboratory assessments in the course of Parkinson’s disease: a clinician’s perspective, Journal of Neural Transmission, 2016, 123, 1, 65

    CrossRef

  5. 5
    T. Kimber, A. Antonini, Peripheral neuropathy and levodopa therapy in Parkinson disease: novel insights, European Journal of Neurology, 2016, 23, 3
  6. 6
    Giovanni Cossu, Maurizio Melis, The peripheral nerve involvement in Parkinson Disease: A multifaceted phenomenon, Parkinsonism & Related Disorders, 2016, 25, 17

    CrossRef

  7. 7
    Antonino Uncini, Roberto Eleopra, Marco Onofrj, Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management, Journal of Neurology, Neurosurgery & Psychiatry, 2015, 86, 5, 490

    CrossRef

  8. 8
    Imke Galazky, Julia Schoof, Sabine Stallforth, Andreas Kupsch, Hans-Jochen Heinze, Christian Kluge, Guillain–Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment, Parkinsonism & Related Disorders, 2014, 20, 1, 125

    CrossRef

  9. 9
    M. Zibetti, A. Merola, C. A. Artusi, L. Rizzi, S. Angrisano, D. Reggio, C. Angelis, M. Rizzone, L. Lopiano, Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience, European Journal of Neurology, 2014, 21, 2
  10. 10
    Manuela Pilleri, Angelo Antonini, Novel levodopa formulations in the treatment of Parkinson's disease, Expert Review of Neurotherapeutics, 2014, 14, 2, 143

    CrossRef

  11. 11
    C. Comi, L. Magistrelli, G.D. Oggioni, M. Carecchio, T. Fleetwood, R. Cantello, F. Mancini, A. Antonini, Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies, Parkinsonism & Related Disorders, 2014, 20, 12, 1329

    CrossRef

  12. 12
    Anne Vital, Sebastien Lepreux, Claude Vital, Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum, Journal of the Peripheral Nervous System, 2014, 19, 4
  13. 13
    F. Mancini, C. Comi, G.D. Oggioni, C. Pacchetti, D. Calandrella, M. Coletti Moja, G. Riboldazzi, S. Tunesi, M. Dal Fante, L. Manfredi, M. Lacerenza, R. Cantello, A. Antonini, Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens, Parkinsonism & Related Disorders, 2014, 20, 1, 27

    CrossRef

  14. 14
    A. Merola, M. Zibetti, M. G. Rizzone, M. Troiano, C. A. Artusi, S. Angrisano, D. Cocito, L. Lopiano, Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients, Acta Neurologica Scandinavica, 2014, 129, 1
  15. 15
    Amer A. Ghavanini, Kurt Kimpinski, Revisiting the Evidence for Neuropathy Caused by Pyridoxine Deficiency and Excess, Journal of Clinical Neuromuscular Disease, 2014, 16, 1, 25

    CrossRef

  16. 16
    Sophie M. Lehnerer, Urban M. Fietzek, Michael Messner, Andres O. Ceballos-Baumann, Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation, Journal of Neural Transmission, 2014, 121, 10, 1269

    CrossRef

  17. 17
    Wolfgang H Jost, Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration, Expert Opinion on Drug Safety, 2014, 13, 4, 447

    CrossRef

  18. 18
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, Á. Sesar, F. Valldeoriola-Serra, R. Yañez, Advanced Parkinson's disease: Clinical characteristics and treatment. Part II, Neurología (English Edition), 2013, 28, 9, 558

    CrossRef

  19. 19
    Thomas Müller, Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson’s disease, Expert Review of Neurotherapeutics, 2013, 13, 6, 707

    CrossRef

  20. 20
    J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, Á. Sesar, F. Valldeoriola-Serra, R. Yañez, Enfermedad de Parkinson avanzada. Características clínicas y tratamiento. Parte II, Neurología, 2013, 28, 9, 558

    CrossRef

  21. 21
    Manuela Pilleri, Konstantinos Koutsikos, Angelo Antonini, Is there room for new non-dopaminergic treatments in Parkinson’s disease?, Journal of Neural Transmission, 2013, 120, 2, 349

    CrossRef

  22. 22
    Roberto Ceravolo, Giovanni Cossu, Monica Bandettini di Poggio, Lucio Santoro, Paolo Barone, Maurizio Zibetti, Daniela Frosini, Valentina Nicoletti, Fiore Manganelli, Rosa Iodice, Marina Picillo, Aristide Merola, Leonardo Lopiano, Alessandra Paribello, Davide Manca, Maurizio Melis, Roberta Marchese, Paolo Borelli, Alessandra Mereu, Paolo Contu, Giovanni Abbruzzese, Ubaldo Bonuccelli, Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study, Movement Disorders, 2013, 28, 10
  23. 23
    Thomas Müller, Teus van Laar, David R. Cornblath, Per Odin, Fabian Klostermann, Francisco J. Grandas, Georg Ebersbach, Peter P. Urban, Francesc Valldeoriola, Angelo Antonini, Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery, Parkinsonism & Related Disorders, 2013, 19, 5, 501

    CrossRef

  24. 24
    Sabine Skodda, Thomas Müller, Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson’s disease under duodopa® therapy, Journal of Neural Transmission, 2013, 120, 2, 315

    CrossRef

  25. 25
    Bernhard Neundörfer, Sind die krankhaften Veränderungen altersphysiologisch?, NeuroTransmitter, 2013, 24, 3, 54

    CrossRef

  26. 26
    F. Klostermann, Intestinal levodopa infusion and COMT inhibition – a promising link, European Journal of Neurology, 2012, 19, 6
  27. 27
    Fabian Klostermann, Constanze Jugel, Thomas Müller, Frank Marzinzik, Malnutritional neuropathy under intestinal levodopa infusion, Journal of Neural Transmission, 2012, 119, 3, 369

    CrossRef

  28. 28
    Dominic C. Paviour, Marie-Helene Marion, PINK1: pumps, paraesthesia, punding and psychosis, Journal of Neurology, 2012, 259, 6, 1241

    CrossRef

  29. 29
    Diego Santos-García, Raúl de la Fuente-Fernández, Francesc Valldeoriola, Antonio Palasí, Fátima Carrillo, Mónica Grande, Pablo Mir, Oriol De Fabregues, Jordi Casanova, Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert, Journal of Neurology, 2012, 259, 8, 1668

    CrossRef

  30. 30
    Thomas Müller, Constanze Jugel, Reinhard Ehret, Georg Ebersbach, Gunar Bengel, Siegfried Muhlack, Fabian Klostermann, Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel, Journal of Neural Transmission, 2011, 118, 9, 1329

    CrossRef

  31. 31
    Thomas Müller, Motor complications, levodopa metabolism and progression of Parkinson's disease, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 7, 847

    CrossRef

  32. 32
    Peter P. Urban, Ingmar Wellach, Siegbert Faiss, Peter Layer, Thorsten Rosenkranz, Karl Knop, Joachim Weis, Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy, Movement Disorders, 2010, 25, 11
  33. 33
    Thomas Müller, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef

  34. 34
    Marco Onofrj, Laura Bonanni, Giovanni Cossu, Davide Manca, Fabrizio Stocchi, Astrid Thomas, Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment, Parkinsonism & Related Disorders, 2009, 15, S233

    CrossRef